Aberrant expression of TIMM17A was observed in 12 different cancers, including LIHC, CESC, LUAD, COAD, BRCA, ESCA, STAD, UCEC, HNCS, LUSC, BLCA, and CHOL. This evidence concerns the gene TIMM17A and cancer.